SCHEMBL25200834

SCHEMBL25200834

CO[Si](CCCNC(C)CC[Si](OC)(OC)OC)(OC)OC

nearest known ligand 0.39

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
LMNA P02545 1/20 0.32
SIGMAR1 Q99720 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6130780 0.84 LMNA (0.41) HTTSMN1; SMN2LMNA
SCHEMBL28446301 0.83 HTT (0.30) HTTSMN1; SMN2
Hydrochloric Acid SCHEMBL23754229 0.83 LMNA (0.44) HTTSMN1; SMN2LMNA
SCHEMBL28225650 0.82 SIGMAR1 (0.33) LMNASIGMAR1
SCHEMBL9476813 0.82 HTT (0.34) HTTSMN1; SMN2
SCHEMBL12190430 0.82 LMNA (0.31) LMNA
SCHEMBL270443 0.81 LMNA (0.34) LMNA
SCHEMBL25180021 0.81
SCHEMBL28457061 0.79 SIGMAR1 (0.31) HTTSMN1; SMN2SIGMAR1
SCHEMBL25311427 0.78 LMNA (0.32) LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11654095-B2 Method for dyeing keratinous material, comprising the use of an organosilicon compound, a chromophoric compound, a modified fatty acid ester and a sealing reagent II HENKEL AG & CO. KGAA (DE) 2023-05-23 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11654095-B2 Method for dyeing keratinous material, comprising the use of an organosilicon compound, a chromophoric compound, a modified fatty acid ester and a sealing reagent II FABP2, KRT18, FABP4 HTT 4524/4885SMN1; SMN2 2573/4885LMNA 714/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.